Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Enterprise Value (2024 - 2025)

Historic Enterprise Value for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to -$76.3 million.

  • Pyxis Oncology's Enterprise Value rose 4734.36% to -$76.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.3 million, marking a year-over-year increase of 4734.36%. This contributed to the annual value of -$126.9 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Enterprise Value is -$76.3 million, which was up 4734.36% from -$88.9 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Enterprise Value ranged from a high of -$76.3 million in Q3 2025 and a low of -$157.0 million during Q1 2024